Sivik Global Healthcare’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-90,000
Closed -$2.35M 54
2023
Q4
$2.35M Buy
+90,000
New +$2.01M 0.98% 37
2016
Q2
Sell
-70,000
Closed -$5.9M 65
2016
Q1
$5.9M Buy
70,000
+43,512
+164% +$3.47M 2.61% 11
2015
Q4
$2.26M Sell
26,488
-13,512
-34% -$1.15M 1.07% 43
2015
Q3
$3.32M Sell
40,000
-19,600
-33% -$1.77M 1.61% 24
2015
Q2
$5.03M Buy
+59,600
New +$5.14M 1.75% 20
2014
Q4
Sell
-70,000
Closed -$4.15M 75
2014
Q3
$4.15M Buy
70,000
+20,000
+40% +$1.31M 1.89% 18
2014
Q2
$3.71M Buy
50,000
+790
+2% +$55.2K 1.87% 24
2014
Q1
$3.25M Sell
49,210
-790
-2% -$49.6K 2.03% 15
2013
Q4
$2.87M Buy
+50,000
New +$2.91M 2.04% 20

Other funds holding WBA

Sivik Global Healthcare's WBA Position: Q1 2024 in Review

Sivik Global Healthcare sold out of Walgreens Boots Alliance (WBA) in Q1 2024, closing a stake of 90,000 shares — an estimated $2.35M sold.

Sivik Global Healthcare first reported a position in WBA in Q4 2013 and held it in 9 quarters. The position peaked at $5.9M in Q1 2016. 995 funds tracked by Wall St. Rank hold WBA as of Q1 2024.

  • Sivik Global Healthcare reported no remaining Walgreens Boots Alliance position as of Q1 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 90,000 Walgreens Boots Alliance shares in Q1 2024, an estimated $2.35M.
  • Sivik Global Healthcare first reported a position in Walgreens Boots Alliance in Q4 2013 and held it in 9 quarters.
  • Sivik Global Healthcare's Walgreens Boots Alliance position peaked at $5.9M in Q1 2016.
  • 995 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q1 2024.

Based on Sivik Global Healthcare's 13F filing for Q1 2024, filed 1 May 2024.